Did medicare part d reduce disparities?

American Journal of Managed Care

Volumn 21, Issue 2, 2015, Pages

  Zissimopoulos, Julie ^a   Joyce, Geoffrey F ^a   Scarpati, Lauren M ^a   Goldman, Dana P ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLACK PERSON; CAUCASIAN; COMORBIDITY; DEMOGRAPHY; DIABETES MELLITUS; DRUG USE; ETHNIC GROUP; FEMALE; HEALTH CARE DELIVERY; HEALTH DISPARITY; HISPANIC; HOUSEHOLD; HUMAN; INCOME; LOWEST INCOME GROUP; MALE; MEDICARE; PATIENT EDUCATION; PHARMACEUTICAL CARE; PRIORITY JOURNAL; RACE; RISK FACTOR; SOCIOECONOMICS; VULNERABLE POPULATION; AFRICAN AMERICAN; AGED; COMPARATIVE STUDY; ECONOMICS; ETHNOLOGY; FACTUAL DATABASE; HEALTH CARE DISPARITY; MEDICATION COMPLIANCE; MULTIVARIATE ANALYSIS; POVERTY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ANTIDIABETIC AGENT;

AFRICAN AMERICANS; AGED; DATABASES, FACTUAL; DIABETES MELLITUS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTHCARE DISPARITIES; HISPANIC AMERICANS; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MEDICARE PART D; MEDICATION ADHERENCE; MULTIVARIATE ANALYSIS; POVERTY; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; UNITED STATES;

EID: 84923249967     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. KRC Research. Seniors' Opinions About Medicare Rx: Sixth Year Update. Washington, DC: KRC Research? 2011.
2. Joyce GF, Zissimopoulos J, Goldman DP. Digesting the doughnut hole. J Health Econ. 2013;32(6):1345-1355.
3. Goldman DP, Smith JP. Can patient selfmanagement help explain the SES health gradient? Proc Natl Acad Sci U S A. 2002;99(16):10929-10934.
4. Haviland AM, Elliott MN, WeechMaldonado R, Hambarsoomian K, Orr N, Hays RD. Racial/ethnic disparities in Medicare Part D experiences. Med Care. 2012;50 suppl:S40-S47.
5. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977-986.
6. Joyce GF, Escarce JJ, Solomon MD, Goldman DP. Employer drug benefit plans and spending on prescription drugs. JAMA. 2002;288(14):1733-1739.
7. Goldman DP, Joyce GF, Escarce JJ, et al. Pharmacy benefits and the use of drugs by the chronically ill. JAMA. 2004;291(19):2344-2350.
8. Goldman DP, Joyce GF, Zheng Y. Prescription drug cost sharing: associations with medication and medical utilization and spending and health. JAMA. 2007;298(1):6169. Review.
9. Huskamp HA, Deverka PA, Epstein AM, Epstein RS, McGuigan KA, Frank RG. The effect of incentive-based formularies on prescription-drug utilization and spending. N Engl J Med. 2003;349(23):2224-2232.
10. Le TT, Bilderback A, Bender B, et al. Do asthma medication beliefs mediate the relationship between minority status and adherence to therapy? J Asthma. 2008;45(1):3337.
11. Mann DM, Ponieman D, Leventhal H, Halm EA. Predictors of adherence to diabetes medications: the role of disease and medication beliefs. J Behav Med. 2009;32(3):278-284.
12. Gellad WF, Haas JS, Safran DG. Race/ethnicity and nonadherence to prescription medications among seniors: results of a national study. J Gen Intern Med. 2007;22(11):1572-1578.
13. Zhang Y, Baik SH. Race/ethnicity, disability, and medication adherence among Medicare beneficiaries with heart failure. J Gen Intern Med. 2013;29(4)602-607.
14. Ngo-Metzger Q, Sorkin DH, Billimek J, Greenfield S, Kaplan SH. The effects of financial pressures on adherence and glucose control among racial/ethnically diverse patients with diabetes. J Gen Intern Med. 2012;27(4):432-437.
15. Tseng CW, Tierney EF, Gerzoff RB, et al. Race/ethnicity and economic differences in costrelated medication underuse among insured adults with diabetes: the translating research into action for diabetes study. Diabetes Care. 2008;31(2):261-266.
16. Lauffenburger JC, Robinson JG, Oramasionwu C, Fang G. Racial/ethnic and gender gaps in the use of and adherence to evidencebased preventive therapies among elderly Medicare Part D beneficiaries after acute myocardial infarction [published online December 10, 2013]. Circulation. 2013;129(7):754A-763A. doi:10.1161/CIRCULATIONAHA.113.002658.
17. Johnson RE, Goodman MJ, Hornbrook MC, Eldredge MB. The impact of increasing patient prescription drug cost sharing on therapeutic classes of drugs received and on the health status of elderly HMO members. Health Serv Res. 1997;32(1):103-122.
18. Tamblyn R, Laprise R, Hanley JA, et al. Adverse events associated with prescription drug costsharing among poor and elderly persons. JAMA. 2001;285(4):421-429.
19. Gaynor M, Li J, Vogt WB. Substitution, Spending Offsets, and Prescription Drug Benefit Design. Forum Health Econ Policy. 2007;10(2):133.
20. Chandra A, Gruber J, McKnight R. Patient costsharing and hospitalization offsets in the elderly. Am Econ Rev. 2010;100(1):193-213.
21. Lurie N, Ward NB, Shapiro MF, Gallego C, Vaghaiwalla R, Brook RH. Termination of MediCal benefits. a followup study one year later. N Engl J Med. 1986;314(19):1266-1268.
22. Chernew M, Gibson TB, YuIsenberg K, Sokol MC, Rosen AB, Fendrick AM. Effects of increased patient cost sharing on socioeconomic disparities in health care. J Gen Intern Med. 2008;23(8):1131-1136.
23. Tseng CW, Brook RH, Keeler E, Steers WN, Mangione CM. Costlowering strategies used by medicare beneficiaries who exceed drug benefit caps and have a gap in drug coverage. JAMA. 2004;292(8):952-960.
24. Hsu J, Price M, Huang J, et al. Unintended consequences of caps on Medicare drug benefits. N Engl J Med. 2006;354(22):2349-2359.